AlphaGrep UK’s Stride LRN Stock Holding History

AlphaGrep UK’s Portfolio LRN Stock Details LRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-2,629	Closed	-$232K	–	856
2026 Q1	$232K	Sell	2,629 -1,429	-35%	-$116K	0.07%	647
2025 Q4	$263K	Buy	+4,058	New	+$368K	0.09%	503

Other funds holding LRN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Jupiter Topco New York $245B AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Impactive Capital New York City, New York $1.4B AUM 13.97% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

AlphaGrep UK's LRN Position: Q2 2026 in Review

AlphaGrep UK sold out of Stride (LRN) in Q2 2026, closing a stake of 2,629 shares — an estimated $232K sold.

AlphaGrep UK first reported a position in LRN in Q4 2025 and held it in 2 quarters. The position peaked at $263K in Q4 2025. 385 funds tracked by Wall St. Rank hold LRN as of Q2 2026.

AlphaGrep UK reported no remaining Stride position as of Q2 2026 after selling out during the quarter.
AlphaGrep UK sold 2,629 Stride shares in Q2 2026, an estimated $232K.
AlphaGrep UK first reported a position in Stride in Q4 2025 and held it in 2 quarters.
AlphaGrep UK's Stride position peaked at $263K in Q4 2025.
385 funds tracked by Wall St. Rank held Stride as of Q2 2026.

Based on AlphaGrep UK's 13F filing for Q2 2026, filed 14 Aug 2026.